Operating under the same phase II protocol as Canadian hospitals in Toronto and Vancouver, the multicenter, international, double-blinded trial has enrolled and treated its first South African participant. “Adding sites in South Africa to our roster of existing sites in Canada will enable us to significantly expedite enrollment,” said Eilat Bain, director of operations.
Read the full article by here: Johannesburg, South Africa News
Submit and get free press releases here: MyPR Free Press Release.
Click HERE to submit your Johannesburg news.
Read more on MyJHB.
Join the fun: Add Your event | Submit a Press Release | Add your listing.
Previous: Ramela bags another ton
